BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Archaeologists uncover details about the Hjortspring boat's origins - 2Everyday Seasonal Positions That Compensate Fairly in the US
- 3Ethiopian earthquakes and volcanic eruptions: earth scientist explains the link
- 4Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
- 5Mexico says a third of 130,000 missing people might be alive, fueling criticism from families
- Top 15 Style Creators Changing the Business
- L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- 'Wuthering Heights' trailer features Margot Robbie and Jacob Elordi in a steamy forbidden romance
- How the Iran war may affect your money and bills
- The Most Enrapturing Authentic Milestones to Visit
- Beating Wellbeing Difficulties: Individual Victories in Health
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- EU top diplomat Kallas arrives in Kiev to commemorate Bucha massacre
- One lightly wounded after Iranian missile barrage targets northern Israel
